Employing 18F-FDG PET/CT for distinguishing benign from metastatic adrenal masses
Conclusion 18F-FDG PET/CT is a precise, non invasive modality for distinguishing benign from metastatic adrenal masses in oncologic patients.
Source: The Egyptian Journal of Radiology and Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Cancer & Oncology | Egypt Health | Liver | Nuclear Medicine | Radiology | Study | Urology & Nephrology